Grand Brilliance Group Holdings Limited (8372.HK)
HKSE · HKD · Healthcare · Medical Distribution
HK$0.166 (+0.61%) as of
Key statistics
- Market cap
- 132.80M
- P/E (TTM)
- 16.60
- EPS (TTM)
- 0.010
- Dividend yield
- 1.51%
- 52-week range
- 0.099 – 0.180
- Beta
- -0.15
- Revenue (TTM)
- 100.71M
- Profit margin
- 8.35%
- Volume
- 120.00k
About Grand Brilliance Group Holdings Limited
Grand Brilliance Group Holdings Limited, an investment holding company, engages in supplying of medical devices in Hong Kong. The company offers medical consumables; medical instruments; and medical equipment. It also provides medical device solutions, such as market trend analysis, sourcing of medical devices, after-sale services, technical support and training services, medical devices leasing services, and quality assurance. Additionally, the company develops autonomous mobile robots solutions. It sells its products to hospitals, clinics, non-profit organizations, charities, universities, and individual users. Grand Brilliance Group Holdings Limited was founded in 1997 and is based in Tsuen Wan, Hong Kong.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Headquarters
- Tsuen Wan, Hong Kong
- Employees
- 51
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.